05:18 PM EDT, 08/20/2025 (MT Newswires) -- James R. Gruber, Chief Financial Officer, on August 19, 2025, sold 41,713 shares in Eton Pharmaceuticals ( ETON ) for $673,714. Following the Form 4 filing with the SEC, Gruber has control over a total of 204,753 common shares of the company, with 204,753 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1710340/000143774925027464/xslF345X05/rdgdoc.xml